Pipeline of Dermatitis Market Reviewed for H2 2015 in New Research Report

India - English

News provided by

Mar 08, 2016, 05:00 ET

PUNE, India, March 8, 2016 /PRNewswire/ --

RnRMarketResearch.com adds "Dermatitis - Pipeline Review, H2 2015" to its store providing an overview of the Dermatitis's therapeutic pipeline with comprehensive information on the therapeutic development for Dermatitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Dermatitis and special features on late-stage and discontinued projects.

Complete report on H2 2015 pipeline review of Dermatitis with 145 market data tables and 16 figures, spread across 445 pages is available at http://www.rnrmarketresearch.com/dermatitis-pipeline-review-h2-2015-market-report.html .

The report also reviews key players involved in the therapeutic development for Dermatitis and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Companies discussed in this Dermatitis Pipeline Review, H2 2015 report include 3SBio Inc., Abeome Corporation, Accolade Pharma LLC, Aclaris Therapeutics, Inc., AlbireoPharma, Aldeyra Therapeutics, Inc., Almirall, S.A., Amgen Inc., Amorepacific Corporation, Anacor Pharmaceuticals, Inc., AnaMar AB, AnaptysBio, Inc., AnGes MG, Inc., Aquinox Pharmaceuticals Inc., arGEN-X BV, AskAt Inc., Athenex, Inc., Biomar Microbial Technologies, Blueberry Therapeutics Ltd, Brickell Biotech, Inc., Celgene Corporation, ChemoCentryx, Inc. , China Biologic Products, Inc., ChironWells GmbH, Chugai Pharmaceutical Co., Ltd., Convoy Therapeutics, Inc., Creabilis SA, Delenex Therapeutics AG, Dermira Inc., Dr. August Wolff GmbH & Co. KG Arzneimittle, Eisai Co., Ltd., Eli Lilly and Company, EpiPharm AG, F. Hoffmann-La Roche Ltd., FAES Farma SA, Foamix Pharmaceuticals Ltd., Fountain Biopharma Inc., GlaxoSmithKline Plc, Glenmark Pharmaceuticals Ltd., GlycaNova Norway AS, Grupo Ferrer Internacional, S.A., Han Wha Pharma Co., Ltd., HanAll Biopharma Co., Ltd., Hapten Sciences, Inc., Herantis Pharma Plc, iCo Therapeutics Inc., ILiAD Biotechnologies, LLC, IMMD Inc., Immune Pharmaceuticals Inc., Immune Response BioPharma, Inc., Inflamalps SA, Japan TobaccoInc., Johnson & Johnson, K-Stemcell Co., Ltd., LegoChem Biosciences, Inc, LEO Pharma A/S, Lixte Biotechnology Holdings, Inc., Madam Therapeutics B.V., Marinomed Biotechnologie GmbH, Maruho Co., Ltd., MedImmune, LLC, Merck & Co., Inc., Mitsubishi Tanabe Pharma Corporation, NeoPharm Co., Ltd., NovaLead Pharma Pvt. Ltd., Novartis AG, Nuvo Research Inc., Orbis Biosciences, Inc., Otsuka Holdings Co., Ltd., Oxagen Limited, Pfizer Inc., Pharis Biotec GmbH, Pharmedartis GmbH, Phosphagenics Limited, ProCertus BioPharm Inc., Provectus Biopharmaceuticals, Inc., Reata Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc., Signum Dermalogix, Inc, SK Chemicals Co., Ltd., Spherium Biomed S.L., Stemnion, Inc, sterna biologicals Gmbh & Co KG, Sucampo Pharmaceuticals, Inc., Sun Pharma Advanced Research Company Ltd., SWITCH Biotech LLC, Takeda Pharmaceutical Company Limited, Thesan Pharmaceuticals, Inc., Valeant Pharmaceuticals International, Inc., Vicore Pharma AB, Vida Therapeutics Inc., Vitae Pharmaceuticals, Inc., VivaCell Biotechnology Espana S.L., Welichem Biotech Inc., XBiotech USA, Inc., Xencor, Inc. and Ziarco Pharma Ltd.

Order a purchase copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=466311 .

Scope of this report: The report provides a snapshot of the global therapeutic landscape of Dermatitis and reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities with key players involved in the therapeutics development for Dermatitis and enlists all their major and minor projects. The report summarizes all the dormant and discontinued pipeline projects, review of the Dermatitis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages, a detailed assessment of monotherapy and combination therapy pipeline projects, coverage of the Dermatitis pipeline on the basis of target, MoA, route of administration and molecule type and latest news and deals relating related to pipeline products.

Another newly published market research report titled on Psoriasis - Pipeline Review, H2 2015 provides comprehensive information on the therapeutic development for Psoriasis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Psoriasis and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Psoriasis Pipeline market research report of 750 pages is available at http://www.rnrmarketresearch.com/psoriasis-pipeline-review-h2-2015-market-report.html .

Explore more reports on Dermatology therapeutics .

About Us:

RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

Contact:
Ritesh Tiwari
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
Maharashtra, India.
Tel: +1-888-391-5441
[email protected]

Connect with Us:

G+ / Google Plus: https://plus.google.com/104156468549256253075/posts

Twitter: https://twitter.com/RnRMR

Facebook: https://www.facebook.com/pages/RnR-Market-Research/413488545356345

SOURCE RnR Market Research